Trial intelligence / Profile preview

Etanercept for Psoriasis After Adalimumab or Infliximab Failure

NCT00967538Phase 4Completed

Sponsor
Innovaderm Research
Start
Sep 2009
Primary completion
Jul 2014
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 4 trial of etanercept in plaque psoriasis, sponsored by Innovaderm Research. Started Sep 2009; status: completed.

02

Drugs

etanercept
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT00967538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00967538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call